OrthoSensor announced plans to launch its VERASENSE Knee System in European Markets. OrthoSensor describes VERASENSE as the first integrated intelligent orthopedic device to provide surgeons with real-time quantitative data on knee implant positioning, limb alignment and soft tissue balance during total knee replacement surgery.
VERASENSE was first clinically used in September 2011, having already received clearance from the FDA for total knee replacement procedures and clear limb alignment.
The VERASENSE Knee System is compatible with multiple leading knee implant systems. It replaces the standard plastic tibial trial spacer during replacement surgery through an intelligent single-use instrument system.
By utilizing proprietary software and advanced real-time data communications, it helps surgeons make evidence-based decisions regarding competent placement, limb alignment and soft tissue balance to achieve balance and stability through a full range of motion with aim of optimizing clinical outcomes.
“We’re pleased to have successfully achieved CE Mark for our VERASENSE technology. This enables us to provide OrthoSensor’s innovative technology to orthopaedic surgeons and patients in markets outside the US and creates significant growth opportunities for our business,” said Jay Pierce, President and CEO of OrthoSensor, Inc.